These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2540383)

  • 1. Confirmation of cannabis use. II. Determination of tetrahydrocannabinol metabolites in urine and plasma by HPLC with ECD.
    Nakahara Y; Sekine H; Cook CE
    J Anal Toxicol; 1989; 13(1):22-4. PubMed ID: 2540383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of THC-COOH and THC-COOH-glucuronide in urine samples by LC/MS/MS.
    Weinmann W; Vogt S; Goerke R; Müller C; Bromberger A
    Forensic Sci Int; 2000 Sep; 113(1-3):381-7. PubMed ID: 10978652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using high-performance liquid chromatography and electrospray ionization mass spectrometry.
    Breindahl T; Andreasen K
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(1):155-64. PubMed ID: 10517232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the determination of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in urine using high performance liquid chromatography with electrochemical detection.
    Isenschmid DS; Caplan YH
    J Anal Toxicol; 1986; 10(5):170-4. PubMed ID: 3022066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
    Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
    J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proof of active cannabis use comparing 11-hydroxy-∆9-tetrahydrocannabinol with 11-nor-9-carboxy-tetrahydrocannabinol concentrations.
    Franz T; Skopp G; Schwarz G; Musshoff F
    Drug Test Anal; 2018 Oct; 10(10):1573-1578. PubMed ID: 29845743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitic acid ester of tetrahydrocannabinol (THC) and palmitic acid diester of 11-hydroxy-THC - Unsuccessful search for additional THC metabolites in human body fluids and tissues.
    Kraemer M; Broecker S; Diehl BWK; Madea B; Hess C
    Forensic Sci Int; 2019 Jan; 294():86-95. PubMed ID: 30481665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid reversed-phase high-performance liquid chromatographic method for the assay of urinary 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid and confirmation of use of cannabis derivatives.
    Bianchi V; Donzelli G
    J Chromatogr B Biomed Appl; 1996 Jan; 675(1):162-7. PubMed ID: 8634759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecularly imprinted polymer for selective determination of Δ9-tetrahydrocannabinol and 11-nor-Δ9-tetrahydrocannabinol carboxylic acid using LC-MS/MS in urine and oral fluid.
    Lendoiro E; de Castro A; Fernández-Vega H; Cela-Pérez MC; López-Vilariño JM; González-Rodríguez MV; Cruz A; López-Rivadulla M
    Anal Bioanal Chem; 2014 Jun; 406(15):3589-97. PubMed ID: 24429976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fast method for aqueous derivatization of THC, OH-THC and THC-COOH in human whole blood and urine samples for routine forensic analyses.
    Stefanelli F; Pesci FG; Giusiani M; Chericoni S
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29135039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
    Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
    J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide.
    Hassenberg C; Clausen F; Hoffmann G; Studer A; Schürenkamp J
    Int J Legal Med; 2020 Nov; 134(6):2105-2119. PubMed ID: 32808050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis intoxication after accidental ingestion in infants: urine and plasma concentrations of Δ-9-tetrahydrocannabinol (THC), THC-COOH and 11-OH-THC in 10 patients.
    Guidet C; Gregoire M; Le Dreau A; Vrignaud B; Deslandes G; Monteil-Ganière C
    Clin Toxicol (Phila); 2020 May; 58(5):421-423. PubMed ID: 31441354
    [No Abstract]   [Full Text] [Related]  

  • 15. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-line coupling of automated solid-phase extraction with high-performance liquid chromatography and electrochemical detection. Quantitation of oxidizable drugs of abuse and their metabolites in plasma and urine.
    Krämer E; Kovar KA
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):167-77. PubMed ID: 10510769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.
    Aizpurua-Olaizola O; Zarandona I; Ortiz L; Navarro P; Etxebarria N; Usobiaga A
    Drug Test Anal; 2017 Apr; 9(4):626-633. PubMed ID: 27341312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly imprinted solid phase extraction for simultaneous determination of Δ9-tetrahydrocannabinol and its main metabolites by gas chromatography-mass spectrometry in urine samples.
    Nestić M; Babić S; Pavlović DM; Sutlović D
    Forensic Sci Int; 2013 Sep; 231(1-3):317-24. PubMed ID: 23890655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.
    Bonnet U; Specka M; Stratmann U; Ochwadt R; Scherbaum N
    Drug Alcohol Depend; 2014 Oct; 143():189-97. PubMed ID: 25127704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an automated liquid-liquid extraction GC/MS method for the determination of THC, 11-OH-THC, and free THC-carboxylic acid (THC-COOH) from blood serum.
    Purschke K; Heinl S; Lerch O; Erdmann F; Veit F
    Anal Bioanal Chem; 2016 Jun; 408(16):4379-88. PubMed ID: 27116418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.